Skip to main content
Carol Hanna, MD, Pathology, Paso Robles, CA

Carol J. Hanna MD

Pathology•Paso Robles, CA

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to View Full Profile

  • 939 Oak StPaso Robles, CA 93446

  • Phone+1 805-237-1011

  • Fax+1 805-237-2788

Are you Dr. Hanna?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Claim this profileNot you? Find your profile

Summary

  • Dr. Carol Hanna, MD is a board certified pathologist in Paso Robles, California. She is currently licensed to practice medicine in California.

Education & Training

  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 1975 - 1979
  • University of Washington School of Medicine
    University of Washington School of MedicineInternship, Transitional Year, 1974 - 1975
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1974

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - 2026
  • Anatomic Pathology & Clinical Pathology
    American Board of Pathology Anatomic Pathology & Clinical Pathology
  • Hematology
    American Board of Pathology Hematology

Press Mentions

  • Research Round-up: Reproductive Health
    Research Round-up: Reproductive HealthDecember 16th, 2020
  • Genome Editing of CCR5 by CRISPR-Cas9 in Mauritian Cynomolgus Macaque Embryos
    Genome Editing of CCR5 by CRISPR-Cas9 in Mauritian Cynomolgus Macaque EmbryosOctober 28th, 2020
  • Treatment of Female Rhesus Macaques with a Somatostatin Receptor Antagonist That Increases Oocyte Fertilization Rates Without Affecting Post-Fertilization Development Outcomes
    Treatment of Female Rhesus Macaques with a Somatostatin Receptor Antagonist That Increases Oocyte Fertilization Rates Without Affecting Post-Fertilization Development OutcomesNovember 15th, 2018

Dr. Carol Hanna, Dr. Carol Hanna, MD, Dr. C Hanna, Dr. Carol J. Hanna